Research output: Contribution to journal › Article › peer-review
20Scopus
citations
Fingerprint
Dive into the research topics of 'A phase 1/2 of a combination of Cetuximab and Taxane for "triple negative" breast cancer patients'. Together they form a unique fingerprint.